As medtech companies, experts and regulators gather in Toronto, FDA leadership changes and the upcoming U.S. presidential ...

From pulsed field ablation to diabetes tech and surgical robots, the updates will provide an early look at how key medtech ...

JNJ's 3Q earnings expected to be $2.21 EPS and $22.16B revenue. Recent acquisitions and drug trials impacting stock's ...

Johnson & Johnson raised its 2024 profit and sales forecasts following strong sales of its oncology drugs. The healthcare ...

Laura Henry, head of finance and talent development, Cirdan, Mark Sterritt British Business Bank director, Bernard McGuire MD ...

A £4.2m MedTech accelerator programme has been launched to provide 140 UK SMEs with grants to tackle key regulatory challenges.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Johnson & Johnson raised its 2024 profit and sales forecasts on Tuesday after reporting strong sales of oncology drugs and ...

Onward Medical signed an exclusive license with CEA-Clinatec to develop and commercialize brain-computer interface (BCI) ...

CMR Surgical obtained a de novo clearance from the FDA for its Versius surgical system, finally allowing its modular, ...

Johnson & Johnson (JNJ) is set to announce Q3 earnings on October 15th. Analysts expect profit of $2.21 on revenue of $22.17B ...

Startups notched 110 deals in the third quarter, compared with 133 in the second quarter. But average deal size held steady, suggesting investors are making “fewer, more focused bets,” according to ...